FLT4 and hepatocellular carcinoma: Along with vascular endothelial growth factor receptor-2 and vascular endothelial growth factor receptor-3, ATX is reportedly involved in vascular development in the liver, which may contribute to HCC onset during the progression of chronic viral hepatitis C (39).